The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 26, 2019

Filed:

Mar. 29, 2017
Applicants:

David R. Hall, Provo, UT (US);

Steven Butala, Provo, UT (US);

Dan Allen, Springville, UT (US);

Daniel Hendricks, Provo, UT (US);

Andrew Nguyen, Provo, UT (US);

Conrad Rosenbrock, Provo, UT (US);

Terrece Pearman, Draper, UT (US);

Inventors:

David R. Hall, Provo, UT (US);

Steven Butala, Provo, UT (US);

Dan Allen, Springville, UT (US);

Daniel Hendricks, Provo, UT (US);

Andrew Nguyen, Provo, UT (US);

Conrad Rosenbrock, Provo, UT (US);

Terrece Pearman, Draper, UT (US);

Assignee:

Other;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/58 (2006.01); G01N 33/94 (2006.01); G01N 33/493 (2006.01); A61B 5/00 (2006.01); G01N 21/64 (2006.01); A61B 10/00 (2006.01); A61B 5/145 (2006.01); A61B 5/1455 (2006.01); A61B 5/20 (2006.01);
U.S. Cl.
CPC ...
G01N 33/94 (2013.01); G01N 33/493 (2013.01); G01N 33/58 (2013.01); A61B 5/0075 (2013.01); A61B 5/1455 (2013.01); A61B 5/14507 (2013.01); A61B 5/207 (2013.01); A61B 5/7271 (2013.01); A61B 10/0038 (2013.01); A61B 2010/0006 (2013.01); G01N 2021/6417 (2013.01); G01N 2021/6439 (2013.01); G01N 2458/00 (2013.01); G01N 2800/52 (2013.01);
Abstract

We disclose a drug tracking system and method of use which may be used to screen a subject's bodily waste in order to assess whether the subject has consumed a drug. The system includes a drug composition which is tagged with at least one artificial sweetener that may be detected in the subject's bodily waste. The subject may consume the tagged drug and a user may obtain a sample of the subject's bodily waste. The bodily waste sample may be analyzed to detect the artificial sweetener or its metabolite. In some embodiments, the result of the analysis of bodily waste may be entered into a database, compared to standards that comprises analyses of a plurality of drug tags, and the identity of the drug tag, and consequently the drug composition, determined.


Find Patent Forward Citations

Loading…